本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tarsus Pharmaceuticals, Inc.

77.64
-0.5900-0.75%
盤後77.640.00000.00%19:30 EDT
成交量:65.88萬
成交額:5,157.82萬
市值:34.07億
市盈率:-71.73
高:79.75
開:78.38
低:77.08
收:78.23
52周最高:91.53
52周最低:48.76
股本:4,388.30萬
流通股本:3,563.83萬
量比:1.19
換手率:1.85%
股息:- -
股息率:- -
每股收益(TTM):-1.0824
每股收益(LYR):-1.5900
淨資產收益率:-13.68%
總資產收益率:-5.48%
市淨率:9.83
市盈率(LYR):-48.83

資料載入中...

2022/05/03

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/05/02

重要事件披露

8-K - Current report
2022/05/02

重要事件披露

8-K - Current report
2022/03/14

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/14

重要事件披露

8-K - Current report
2022/03/14

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/02

重要事件披露

8-K - Current report
2022/01/28

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/04

重要事件披露

8-K - Current report
2021/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/09

重要事件披露

8-K - Current report
2021/11/03

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/01

重要事件披露

8-K - Current report
2021/08/12

重要事件披露

8-K - Current report